# Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

> **NCT06093126** · PHASE4 · RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 1 (estimated)

## Conditions studied

- Insomnia
- Dementia
- Frontotemporal Dementia

## Interventions

- **DRUG:** Lemborexant 5 MG

## Key facts

- **NCT ID:** NCT06093126
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-11
- **Primary completion:** 2028-12-11
- **Final completion:** 2028-12-11
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06093126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06093126, "Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06093126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*